RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation |  FREE
Michael A. Fischer, MD, MS; Charles A. Morris, MD, MPH; Wolfgang C. Winkelmayer, MD, ScD; et al.
Arch Intern Med. 2007;167(8):840-846. doi:10.1001/archinte.167.8.840.

Editor's Correspondence | 
Jerry L. Spivak, MD
Arch Intern Med. 2006;166(17):1923-1924. doi:10.1001/archinte.166.17.1923-b.

Review Article |  FREE
David H. Henry, MD; Peter Bowers, MD; Michael T. Romano, PhD; et al.
Arch Intern Med. 2004;164(3):262-276. doi:10.1001/archinte.164.3.262.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
Editorial  | 
Evaluation of Agents to Reduce Infarct Size:  It Can Be Quite REVEALing
Deepak L. Bhatt, MD, MPH
Original Contribution  | 
Intravenous Erythropoietin in Patients With ST-Segment Elevation Myocardial Infarction:  REVEAL: A Randomized Controlled Trial
Samer S. Najjar, MD; Sunil V. Rao, MD; Chiara Melloni, MD, MHS; et al.
JAMA Pediatrics
Article  | 
Comparison of 2 Iron Doses in Infants Receiving Recombinant Human Erythropoietin Therapy
Shahid Nazir, MD; Ricardo L. Peverini, MD; Douglas D. Deming, MD; et al.
JAMA Neurology
Observation  | 
Cerebral Venous Thrombosis Associated With Epoetin Alfa Therapy
Pasquale F. Finelli, MD; Matthew D. Carley, MD